WASHINGTON, Aug. 17 (TNSLrpt) -- The Health and Human Services Inspector General issued the following report (OEI-03-26-00060) entitled "Comparison of Average Sales Prices and Average Manufacturer Prices: Results for the First Quarter of 2026" filed under CMS:

Here are excerpts:

* * *

Why OIG Did This Review

* When Congress established average sales price (ASP) as the basis for reimbursement for Medicare Part B drugs (generally, drugs . . .

Click here for more information about our products